Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis

被引:31
|
作者
Garay, Laura [1 ,2 ]
Gonzalez Deniselle, Maria Claudia [1 ,3 ]
Sitruk-Ware, Regine [4 ]
Guennoun, Rachida [5 ]
Schumacher, Michael [5 ]
De Nicola, Alejandro F. [1 ,2 ]
机构
[1] Inst Biol & Med Expt, Lab Neuroendocrine Biochem, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Med, Dept Human Biochem, RA-1053 Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Med, Dept Physiol, RA-1053 Buenos Aires, DF, Argentina
[4] Rockefeller Univ, Populat Council, New York, NY 10021 USA
[5] Univ Paris Sud, UMR Inserm 788, Le Kremlin Bicetre, France
关键词
Experimental autoimmune encephalomyelitis; Nestorone; Microglia; Behavior; ADULT HIPPOCAMPAL NEUROGENESIS; MULTIPLE-SCLEROSIS; INFLAMMATION ALTERS; CELL-PROLIFERATION; DENTATE GYRUS; BRAIN-INJURY; SPINAL-CORD; MOUSE MODEL; MALE-MICE; NEUROPROTECTION;
D O I
10.1016/j.jneuroim.2014.08.619
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Progesterone plays a protective role in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). Besides spinal cord neuropathology, MS patients present a dysfunctional hippocampus. In this work we studied the therapeutic effects of the progestin Nestorone in the brain of mice with chronic EAE. Nestorone decreased clinical grade and enhanced motor behavior. In addition, it increased cell proliferation and doublecortin positive neuroblasts in the hippocampus, increased GABAergic interneurons and attenuated the number of Iba1 + microglia/macrophages, events possibly linked to enhancement of neurogenesis. Therefore, Nestorone protected against hippocampus abnormalities and improved functional outcomes of EAE mice, suggesting its potential value for MS. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [21] Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice
    Lieberknecht, Vicente
    Junqueira, Stella C.
    Cunha, Mauricio P.
    Barbosa, Thais A.
    de Souza, Luiz F.
    Coelho, Igor S.
    Santos, Adair R. S.
    Rodrigues, Ana Lucia S.
    Dafre, Alcir L.
    Dutra, Rafael C.
    MOLECULAR NEUROBIOLOGY, 2017, 54 (02) : 1033 - 1045
  • [22] Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis
    Polak, PE
    Kalinin, S
    Dello Russo, C
    Gavrilyuk, V
    Sharp, A
    Peters, JM
    Richardson, J
    Willson, TM
    Weinberg, G
    Feinstein, DL
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 168 (1-2) : 65 - 75
  • [23] Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
    Banisadr, Ghazal
    Schwartz, Samantha R.
    Podojil, Joseph R.
    Piccinini, Linda A.
    Lanker, Stefan
    Miller, Stephen D.
    Miller, Richard J.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2014, 9 (03) : 438 - 445
  • [24] Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
    Ceylan, Ulas
    Haupeltshofer, Steffen
    Kaemper, Laura
    Dann, Justus
    Ambrosius, Bjorn
    Gold, Ralf
    Faissner, Simon
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
    Ni, X
    Geller, EB
    Eppihimer, MJ
    Eisenstein, TK
    Adler, MW
    Tuma, RF
    MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (02) : 158 - 164
  • [26] Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis
    Kim, Roy Y.
    Mangu, Darian
    Hoffman, Alexandria S.
    Kovash, Rojan
    Jung, Eunice
    Itoh, Noriko
    Voskuhl, Rhonda
    BRAIN, 2018, 141 : 132 - 147
  • [27] Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats
    Elo, Petri
    Li, Xiang-Guo
    Liljenback, Heidi
    Helin, Semi
    Teuho, Jarmo
    Koskensalo, Kalle
    Saunavaara, Virva
    Marjamaki, Paivi
    Oikonen, Vesa
    Virta, Jenni
    Chen, Qingshou
    Low, Philip S.
    Knuuti, Juhani
    Jalkanen, Sirpa
    Airas, Laura
    Roivainen, Anne
    JOURNAL OF NEUROINFLAMMATION, 2019, 16 (01)
  • [28] Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis
    Voskuhl, Rhonda R.
    MacKenzie-Graham, Allan
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [29] The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis
    Weilbach, FX
    Chan, A
    Toyka, KV
    Gold, R
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 135 (01) : 49 - 55
  • [30] CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
    Fife, BT
    Huffnagle, GB
    Kuziel, WA
    Karpus, WJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (06) : 899 - 905